312 related articles for article (PubMed ID: 8262677)
1. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients.
Hirai M; Azuma T; Ito S; Kato T; Kohli Y; Fujiki N
Int J Cancer; 1994 Jan; 56(1):56-60. PubMed ID: 8262677
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in Japan.
Ogura K; Kanai F; Maeda S; Yoshida H; Ogura M; Lan KH; Hirota K; Kawabe T; Shiratori Y; Omata M
Gut; 1997 Oct; 41(4):463-8. PubMed ID: 9391243
[TBL] [Abstract][Full Text] [Related]
3. Production of monoclonal antibodies neutralizing vacuolation of cultured cells by Helicobacter pylori cytotoxin.
Yamaguchi H; Osaki T; Taguchi H; Kamiya S
FEMS Microbiol Lett; 1998 Nov; 168(2):277-82. PubMed ID: 9835039
[TBL] [Abstract][Full Text] [Related]
4. The interrelationship between Helicobacter pylori vacuolating cytotoxin and gastric carcinoma.
de Figueiredo Soares T; de Magalhães Queiroz DM; Mendes EN; Rocha GA; Rocha Oliveira AM; Alvares Cabral MM; de Oliveira CA
Am J Gastroenterol; 1998 Oct; 93(10):1841-7. PubMed ID: 9772042
[TBL] [Abstract][Full Text] [Related]
5. Detection of serum antibodies to CagA and VacA and of serum neutralizing activity for vacuolating cytotoxin in patients with Helicobacter pylori-induced gastritis.
Donati M; Moreno S; Storni E; Tucci A; Poli L; Mazzoni C; Varoli O; Sambri V; Farencena A; Cevenini R
Clin Diagn Lab Immunol; 1997 Jul; 4(4):478-82. PubMed ID: 9220168
[TBL] [Abstract][Full Text] [Related]
6. Neutralisation of vacuolating activity of cytotoxin by serum antibodies of Helicobacter pylori infected patients.
Gościniak G; Przondo-Mordarska A; Iwańczak B; Poniewierka E
Acta Microbiol Pol; 2000; 49(2):113-20. PubMed ID: 11093674
[TBL] [Abstract][Full Text] [Related]
7. Vacuolating cytotoxin production by Helicobacter pylori isolates from peptic ulcer, atrophic gastritis and gastric carcinoma patients.
Murakita H; Hirai M; Ito S; Azuma T; Kato T; Kohli Y
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S29-31. PubMed ID: 7735931
[TBL] [Abstract][Full Text] [Related]
8. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country.
Mitchell HM; Hazell SL; Li YY; Hu PJ
Am J Gastroenterol; 1996 Sep; 91(9):1785-8. PubMed ID: 8792699
[TBL] [Abstract][Full Text] [Related]
9. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo.
Cover TL; Cao P; Lind CD; Tham KT; Blaser MJ
Infect Immun; 1993 Dec; 61(12):5008-12. PubMed ID: 8225576
[TBL] [Abstract][Full Text] [Related]
10. Neutralisation of cytotoxic vacuolating activity by serum antibodies of Helicobacter pylori-infected patients.
Gościniak G; Przondo-Mordarska A; Iwańczak B; Poniewierka E
Int J Med Microbiol; 2001 Apr; 291(1):27-32. PubMed ID: 11403408
[TBL] [Abstract][Full Text] [Related]
11. Relationship between antibody to cytotoxin and Helicobacter pylori infection.
Gościniak G; Przondo-Mordarska A; Poniewierka E; Iwańczak B; Bilska A
J Physiol Pharmacol; 1997 Sep; 48(3):415-21. PubMed ID: 9376624
[TBL] [Abstract][Full Text] [Related]
12. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany.
Miehlke S; Kirsch C; Agha-Amiri K; Günther T; Lehn N; Malfertheiner P; Stolte M; Ehninger G; Bayerdörffer E
Int J Cancer; 2000 Aug; 87(3):322-7. PubMed ID: 10897035
[TBL] [Abstract][Full Text] [Related]
13. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis.
Fox JG; Correa P; Taylor NS; Thompson N; Fontham E; Janney F; Sobhan M; Ruiz B; Hunter F
Am J Gastroenterol; 1992 Nov; 87(11):1554-60. PubMed ID: 1442673
[TBL] [Abstract][Full Text] [Related]
14. Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori.
Cover TL; Cao P; Murthy UK; Sipple MS; Blaser MJ
J Clin Invest; 1992 Sep; 90(3):913-8. PubMed ID: 1522241
[TBL] [Abstract][Full Text] [Related]
15. Expression of vacuolating cytotoxin in clinical isolates of Helicobacter pylori.
Kodama K; Fujioka T; Ito A; Kubota T; Murakami K; Nasu M
J Gastroenterol; 1996 Nov; 31 Suppl 9():9-11. PubMed ID: 8959510
[TBL] [Abstract][Full Text] [Related]
16. Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection.
Bagheri N; Shirzad H; Elahi S; Azadegan-Dehkordi F; Rahimian G; Shafigh M; Rashidii R; Sarafnejad A; Rafieian-Kopaei M; Faridani R; Tahmasbi K; Kheiri S; Razavi A
Microb Pathog; 2017 Sep; 110():165-175. PubMed ID: 28666843
[TBL] [Abstract][Full Text] [Related]
17. Neutralising antibodies to the vacuolating toxin of Helicobacter pylori in gastritis only and peptic ulcer patients.
Pereira Lage A; Glupczynski Y; Goossens H; Burette A; Butzler JP
Zentralbl Bakteriol; 1993 Sep; 280(1-2):197-202. PubMed ID: 8280942
[TBL] [Abstract][Full Text] [Related]
18. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.
Beales IL; Crabtree JE; Scunes D; Covacci A; Calam J
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):645-9. PubMed ID: 8853252
[TBL] [Abstract][Full Text] [Related]
20. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
